Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia

This study has been terminated.

( subject accrual and data analysis is completed. )

Study NCT00002778 Information provided by Sidney Kimmel Comprehensive Cancer Center

First Received: November 1, 1999 Last Updated: July 19, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	July 2010
Primary Completion Date:	February 2005 (Final data collection date for primary outcome measure)